Welcome to Flow Pharma Inc.

Page Loading...

Menu
blob-1
blob-2

Research Publications

  1. C.V. Herst, S. Burkholz, J. Sidney, A. Sette, P.E. Harris, S. Massey, T. Brasel, E. Cunha-Neto, D.S. Rosa, W.C.H. Chao, R. Carback, T. Hodge, L. Wang, S. Ciotlos, P. Lloyd, R. Rubsamen, An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design, Vaccine, Volume 38, Issue 28, 2020, Pages 4464-4475. [PDF] [Publisher Website]
  2. R.M. Rubsamen, C.V. Herst, P.M. Lloyd, D.E. Heckerman, Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants, Vaccine, Volume 32, Issue 33, 2014, Pages 4111-4116, ISSN 0264-410X. [PDF] [Publisher Website]
  3. Cunha-Neto, E., Rosa, D. S., Harris, P. E., Olson, T., Morrow, A., Ciotlos, S., et al. (2017). An approach for a synthetic CTL vaccine design against Zika flavivirus using class I and class II epitopes identified by computer modeling. Front. Immunol. 8:640. [PDF] [Publisher Website]
  4. Stall AC, Becker E, Ludwig SC, Gelb D, Poelstra KA. Reduction of postoperative spinal implant infection using gentamicin microspheres. Spine (Phila Pa 1976) 2009;34:479–483. [PDF] [Author Website]